Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data.

by Christopher M Black, Eric Yu, Eilish McCann, Sumesh Kachroo
Published 2016-01-01

Physician Perceptions about the Barriers to Prompt Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease

by Davneet Judge, Jenna Roberts, Rezaul Khandker, Baishali Ambegaonkar, Christopher M. Black
Published 2019-01-01

Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany.

by Emma Sullivan, James Piercy, John Waller, Christopher M Black, Sumesh Kachroo
Published 2017-01-01

Physician Practice Patterns Associated with Diagnostic Evaluation of Patients with Suspected Mild Cognitive Impairment and Alzheimer’s Disease

by Davneet Judge, Jenna Roberts, Rezaul Karim Khandker, Baishali Ambegaonkar, Christopher M. Black
Published 2019-01-01

Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience

by Sami Hoque, Christopher M Black, Amy Puenpatom, Simona Boccaletti, Chloe Green, Jenna Roberts, Ivana Rajkovic, Gary Milligan
Published 2020-11-01

Non-professional caregiver burden is associated with the severity of patients' cognitive impairment.

by Christopher M Black, Craig W Ritchie, Rezaul K Khandker, Robert Wood, Eddie Jones, Xiaohan Hu, Baishali M Ambegaonkar
Published 2018-01-01

Disparity in Access to Oncology Precision Care: A Geospatial Analysis of Driving Distances to Genetic Counselors in the U.S.

by Mathias M. J. Bellaiche, Winnie Fan, Harold John Walbert, Egan H. McClave, Bradley L. Goodnight, Fred H. Sieling, Rebekah A. Moore, Weilin Meng, Christopher M. Black
Published 2021-06-01